[Evaluations of double filtration plasma perfusion (DFPP) for arteriosclerosis obliterans (ASO) in maintenance hemodialysis patients].
Chiba
Eiichi
E
Jinyükai Iwamizawa Clinic.
D001162:Arteriosclerosis Obliterans / Q000209:etiology / Q000628:therapy*; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000150:complications; D005260:Female; D005340:Fibrinogen; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D010758:Phosphorus / Q000097:blood; D010956:Plasmapheresis / Q000379:methods*; D006435:Renal Dialysis; D016896:Treatment Outcome
D010758:Phosphorus; D005340:Fibrinogen